{
  "id": "results-validation-root",
  "requirements": "Results Validation",
  "sequential": false,
  "sub_tasks": [
    {
      "id": "output-format-validation",
      "requirements": "Output Format Validation",
      "weight": 1,
      "sequential": true,
      "sub_tasks": [
        {
          "id": "csv-file-exists",
          "requirements": "CSV File Exists",
          "sequential": false,
          "critical": false,
          "scoring": "1/0",
          "sub_tasks": []
        },
        {
          "id": "column-name-exists",
          "requirements": "Column Name Exists",
          "sequential": true,
          "critical": false,
          "sub_tasks": [
            {
              "id": "early-prevalence-column-exists",
              "requirements": "Column exists for early window (first 48h) GLP-1 RA prescription prevalence percentage (e.g., 'early_prevalence_pct').",
              "sequential": false,
              "critical": false,
              "scoring": "1/0",
              "sub_tasks": []
            },
            {
              "id": "final-prevalence-column-exists",
              "requirements": "Column exists for final window (final 12h) GLP-1 RA prescription prevalence percentage (e.g., 'final_prevalence_pct').",
              "sequential": false,
              "critical": false,
              "scoring": "1/0",
              "sub_tasks": []
            },
            {
              "id": "absolute-change-column-exists",
              "requirements": "Column exists for absolute change in prevalence percentage points (e.g., 'absolute_change_pct_points').",
              "sequential": false,
              "critical": false,
              "scoring": "1/0",
              "sub_tasks": []
            },
            {
              "id": "relative-change-column-exists",
              "requirements": "Column exists for relative change in prevalence percentage (e.g., 'relative_change_pct').",
              "sequential": false,
              "critical": false,
              "scoring": "1/0",
              "sub_tasks": []
            }
          ]
        },
        {
          "id": "no-null-empty-values",
          "requirements": "No NULL/Empty Values in key columns ('early_prevalence_pct', 'final_prevalence_pct', 'absolute_change_pct_points', 'relative_change_pct').",
          "sequential": false,
          "critical": false,
          "scoring": "1/0",
          "sub_tasks": []
        }
      ]
    },
    {
      "id": "output-feature-validation",
      "requirements": "Output Feature Validation",
      "weight": 2,
      "sequential": false,
      "sub_tasks": [
        {
          "id": "early-prevalence-validation",
          "requirements": "Validate 'early_prevalence_pct' column value.",
          "sequential": true,
          "sub_tasks": [
            {
              "id": "early-prevalence-plausible",
              "requirements": "Value for early window GLP-1 RA prevalence is clinically plausible (0.0 to 10.0%).",
              "sequential": false,
              "critical": false,
              "scoring": "1/0",
              "sub_tasks": []
            },
            {
              "id": "early-prevalence-acceptable",
              "requirements": "Value for early window GLP-1 RA prevalence is within an acceptable range for this cohort (0.05 to 2.5%). The value 0.145 is acceptable.",
              "sequential": false,
              "critical": false,
              "scoring": "1/0",
              "sub_tasks": []
            }
          ]
        },
        {
          "id": "final-prevalence-validation",
          "requirements": "Validate 'final_prevalence_pct' column value.",
          "sequential": true,
          "sub_tasks": [
            {
              "id": "final-prevalence-plausible",
              "requirements": "Value for final window GLP-1 RA prevalence is clinically plausible (0.0 to 10.0%).",
              "sequential": false,
              "critical": false,
              "scoring": "1/0",
              "sub_tasks": []
            },
            {
              "id": "final-prevalence-acceptable",
              "requirements": "Value for final window GLP-1 RA prevalence is within an acceptable range for this cohort (0.0 to 2.5%). The value 0.0 is acceptable.",
              "sequential": false,
              "critical": false,
              "scoring": "1/0",
              "sub_tasks": []
            }
          ]
        },
        {
          "id": "absolute-change-validation",
          "requirements": "Validate 'absolute_change_pct_points' column value.",
          "sequential": true,
          "sub_tasks": [
            {
              "id": "absolute-change-plausible",
              "requirements": "Value for absolute change is mathematically plausible (-10.0 to 10.0 percentage points).",
              "sequential": false,
              "critical": false,
              "scoring": "1/0",
              "sub_tasks": []
            },
            {
              "id": "absolute-change-acceptable",
              "requirements": "Value for absolute change is within an acceptable range (-2.5 to 2.5 percentage points). The value -0.145 is acceptable.",
              "sequential": false,
              "critical": false,
              "scoring": "1/0",
              "sub_tasks": []
            }
          ]
        },
        {
          "id": "relative-change-validation",
          "requirements": "Validate 'relative_change_pct' column value.",
          "sequential": true,
          "sub_tasks": [
            {
              "id": "relative-change-plausible",
              "requirements": "Value for relative change is mathematically plausible (e.g., -100.0 to a large positive number if final prevalence is higher). A value of -100.0 is plausible.",
              "sequential": false,
              "critical": false,
              "scoring": "1/0",
              "sub_tasks": []
            },
            {
              "id": "relative-change-acceptable",
              "requirements": "Value for relative change is consistent with the prevalence values. Given early=0.145 and final=0.0, the relative change is indeed -100.0%.",
              "sequential": false,
              "critical": false,
              "scoring": "1/0",
              "sub_tasks": []
            }
          ]
        }
      ]
    }
  ]
}
